Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc. has an enterprise value of approximately $430 million, providing a potential for significant upside in its stock value, especially if its partnership with Novopro proves to be successful. The company's management anticipates improved efficiency in executing Phase 1 trials for its products, particularly with SEP-786, driven by prior experience. Additionally, the promising performance of SEP-631, which has the potential to mirror the success of Xolair—an anti-IgE monoclonal antibody with nearly $3.9 billion in sales in 2023—coupled with preclinical data indicating enhanced dosing convenience and a longer half-life for candidates, reinforces a positive outlook for Septerna's future growth and development.

Bears say

Septerna Inc faces several risks that contribute to a negative outlook on its stock, including potential delays in clinical development for key candidates like SEP-631 and other pipeline products. Setbacks in clinical trials and partnership uncertainties, particularly with Novo Nordisk, could hinder the company’s progress and impact its market position. Additionally, concerns over achieving market penetration and the possibility of long-term dilution further exacerbate the financial outlook, as highlighted by a recent transaction in the obesity sector that suggests a valuation gap for Septerna.

Septerna Inc (SEPN) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.